Plenary Paper HEMATOPOIESIS AND STEM CELLS Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1

نویسندگان

  • Yiran Guo
  • Melissa Kartawinata
  • Jiankang Li
  • Hilda A. Pickett
  • Juliana Teo
  • Tatjana Kilo
  • Pasquale M. Barbaro
  • Brendan Keating
  • Yulan Chen
  • Lifeng Tian
  • Ahmad Al-Odaib
  • Roger R. Reddel
  • John Christodoulou
  • Xun Xu
  • Hakon Hakonarson
  • Tracy M. Bryan
چکیده

Telomeres are the repetitive DNA–protein complexes at the ends of linear chromosomes, which shorten with every cell division in human somatic cells. Telomere shortening eventually leads to the activation of a DNA damage response and cellular senescence or apoptosis. Germ cells, stem cells, and cells in the developing human embryo overcome telomere shortening by expression of the ribonucleoprotein enzyme telomerase. Telomerase catalyzes addition of telomeric DNA repeats to chromosome ends by reverse transcription of a template sequence within its integral RNA subunit (hTR in humans). The core active human telomerase complex consists of hTR, the reverse-transcriptase protein subunit (hTERT), and the RNA-binding protein dyskerin. Telomerase interacts with many other proteins during its biogenesis and transport to the telomere, such as the protein TCAB1 (also known as WDR79 and WRAP53), which is responsible for trafficking telomerase to nuclear Cajal bodies and from there to the telomere. Individuals who inherit extremely short telomeres are at risk of developing one of a group of disorders collectively termed “short telomere syndromes.” The first of these diseases linked to short telomeres was dyskeratosis congenita (DC), defined by a mucocutaneous triad of abnormal skin pigmentation, oral leukoplakia, and nail dystrophy and characterized by progressive bonemarrow failure due to depletion of functional hematopoietic progenitor and stem cells. Patients with DC, or its more severe variants Revesz syndrome and Hoyeraal-Hreidarsson syndrome, harbor deleterious mutations in the genes encoding dyskerin, hTR, hTERT, TCAB1, the dyskerin-associated proteins Nop10 and Nhp2, or the telomere-binding proteins TIN2, CTC1, and RTel1. Patients with acquired or familial aplastic anemia, but lacking the other clinical features of DC, can also carry short telomeres and mutations in the genes encoding hTR or hTERT. The telomere-binding protein TPP1 (encoded by the gene adrenocortical dysplasia homolog [mouse] [ACD] and previously known as PTOP, PIP1, or TINT2) is critical for telomere stability and length regulation. TPP1 binds to the telomere via interaction with TIN2 and in turn tethers the single-stranded DNA binding protein Pot1 to telomeres. TPP1 is required for Pot1 to perform its role in protecting telomeres from being recognized as DNA damage. The Pot1/TPP1 heterodimer also has a separate role in promoting the processivity of telomerase, ie, its ability to synthesize long tracts of

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.

Dyskeratosis congenita (DC) is an inherited multisystem disorder, characterized by oral leukoplakia, nail dystrophy, and abnormal skin pigmentation, as well as high rates of bone marrow (BM) failure, solid tumors, and other medical problems such as osteopenia. DC and telomere biology disorders (collectively referred to as TBD here) are caused by germline mutations in telomere biology genes lead...

متن کامل

Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.

Mutations in DKC1, encoding telomerase associated protein dyskerin, cause X-linked dyskeratosis congenita (DC), a bone marrow (BM) failure, and cancer susceptibility syndrome. Decreased accumulation of telomerase RNA resulting in excessive telomere shortening and premature cellular senescence is thought to be the primary cause of disease in X-linked DC. Affected tissues are those that require c...

متن کامل

p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita

Dyskeratosis congenita (DC) is a bone marrow failure syndrome associated with telomere dysfunction. The progression and molecular determinants of hematopoietic failure in DC remain poorly understood. Here, we use the directed differentiation of human embryonic stem cells harboring clinically relevant mutations in telomerase to understand the consequences of DC-associated mutations on the primit...

متن کامل

Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita.

Dyskeratosis congenita (DC) is an inherited bone marrow (BM) failure syndrome associated with mutations in telomerase genes and the acquisition of shortened telomeres in blood cells. To investigate the basis of the compromised hematopoiesis seen in DC, we analyzed cells from granulocyte colony-stimulating factor mobilized peripheral blood (mPB) collections from 5 members of a family with autoso...

متن کامل

HEMATOPOIESIS AND STEM CELLS Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita

TRF1 is part of the shelterin complex, which binds telomeres and it is essential for their protection. Ablation of TRF1 induces sister telomere fusions and aberrant numbers of telomeric signals associated with telomere fragility. Dyskeratosis congenita is characterized by a mucocutaneous triad, bone marrow failure (BMF), and presence of short telomeres because of mutations in telomerase. A subs...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014